China Market Intelligence

June 14th, 2017
By David Solomon

Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.

May 3rd, 2017
By David Solomon

As China aims to expand nationwide health insurance, improve patient access to care, strengthen primary care, and deepen investment in rural regions, US companies want in on the

April 5th, 2017
By David Solomon

The Chinese healthcare sector, which accounted for 6 percent of the country’s GDP in 2016, is expected to capture a 10 percent share in the coming